| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 28 |
| 1 | ALBUTEROL SULFATE | 23 |
| 2 | TIOTROPIUM BROMIDE | 17 |
| 3 | MONTELUKAST SODIUM | 16 |
| 4 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 14 |
| 5 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 12 |
| 6 | METFORMIN | 12 |
| 7 | METFORMIN ER 500 MG | 11 |
| 8 | METFORMIN ER 750 MG | 11 |
| 9 | ASPIRIN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 1 | ACLIDINIUM BROMIDE | 7 | 0.0011 |
| 2 | GLYCOPYRROLATE | 4 | 0.0007 |
| 3 | ENSIFENTRINE | 1 | 0.0005 |
| 4 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 5 | CEFADROXIL | 1 | 0.0005 |
| 6 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 7 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 14 | 0.0004 |
| 8 | TELMISARTAN | 7 | 0.0004 |
| 9 | CICLESONIDE | 5 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Anti-IgE [EPC] | 28 | 0.0003 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 3 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Aminoglycoside Antibacterial [EPC] | 7 | 0.0002 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 6 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 7 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |